Warwick J, Will O, Allgood P, Miller R, Duffy S, Greenberg D
Imperial Clinical Trials Unit, School of Public Health, Faculty of Medicine, Imperial College London, London, UK.
Colorectal Dis. 2013;15(10):1243-52. doi: 10.1111/codi.12308.
National guidelines for colorectal cancer management aim to optimize cancer outcomes irrespective of postcode. However, in order to ensure equal performance of cancer services, variation in outcome must be monitored and intelligently assessed. In this study, detailed regional cancer registry data were used to quantify and explore the reasons for variation in colorectal cancer outcomes at nine hospitals in East Anglia.
We analysed data on colorectal cancers registered by the Eastern Cancer Registry and Information Centre (ECRIC) between 1999 and 2005. Tumours were grouped by site, in keeping with surgical resection. Multivariable Cox regression models were used to identify the effects of patient, disease and treatment variables on an individual's risk of death.
After adjusting for demographic, disease and treatment variables there were significant differences in survival among hospitals in emergency admissions with cancer of the right colon, in elective admissions with cancer of the left, sigmoid or recto-sigmoid colon and in emergency admissions with cancer of the rectum. There were also differences among hospitals in terms of perioperative death, nonsurgical management and numbers of nodes examined. For rectal cancers, rates of anterior resection compared with abdominoperineal excision differed, as well as the use of neoadjuvant radiotherapy.
Detailed analysis of demographic, disease and treatment factors are required when comparing the survival of individuals with colorectal cancer across hospitals. The results imply that cancer management was not consistent across East Anglia in 1999-2005 but the reasons for this are uncertain. Nevertheless, 5-year age-standardized survival with colon cancer in the Anglia Cancer Network region is currently among the best in the UK.
结直肠癌管理的国家指南旨在优化癌症治疗结果,而不受邮政编码的影响。然而,为确保癌症服务的同等绩效,必须对结果差异进行监测并进行明智评估。在本研究中,详细的区域癌症登记数据被用于量化和探究东安格利亚九家医院结直肠癌治疗结果差异的原因。
我们分析了东部癌症登记与信息中心(ECRIC)在1999年至2005年期间登记的结直肠癌数据。肿瘤按部位分组,以符合手术切除情况。多变量Cox回归模型用于确定患者、疾病和治疗变量对个体死亡风险的影响。
在对人口统计学、疾病和治疗变量进行调整后,右半结肠癌急诊入院患者、左半结肠、乙状结肠或直肠乙状结肠交界处癌择期入院患者以及直肠癌急诊入院患者在不同医院之间的生存率存在显著差异。不同医院在围手术期死亡、非手术治疗以及检查的淋巴结数量方面也存在差异。对于直肠癌,前切除术与腹会阴联合切除术的比例不同,新辅助放疗的使用情况也不同。
在比较不同医院结直肠癌患者的生存率时,需要对人口统计学、疾病和治疗因素进行详细分析。结果表明,1999 - 2005年期间东安格利亚地区的癌症管理并不一致,但其原因尚不确定。尽管如此,东安格利亚癌症网络地区结肠癌的5年年龄标准化生存率目前在英国处于最佳水平之一。